Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Science Advances|March 31, 2023
Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identityRajendran Sanalkumar, Rui Dong, Lukuo Lee, et al.
Journal of Translational Medicine|May 19, 2025
The human RNASET2 alarmin-like molecule differentially affects prostate cancer cells behavior in both cell autonomous and non-cell autonomous mannersRossella Roncoroni, Denisa Baci, Martina Cucchiara, et al.
Cell Stem Cell|October 3, 2015
Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic EnteropathyFrancesca D'Addio, Stefano La Rosa, Anna Maestroni, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboonsRodolfo Guardado-Mendoza, Alberto M Davalli, Alberto O Chavez, et al.
The American Journal of Pathology|December 3, 2014
Chronic continuous exenatide infusion does not cause pancreatic inflammation and ductal hyperplasia in non-human primatesTeresa Vanessa Fiorentino, Michael Owston, Gregory Abrahamian, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2014
Role of podocyte B7-1 in diabetic nephropathyPaolo Fiorina, Andrea Vergani, Roberto Bassi, et al.
Nature Communications|April 28, 2022
EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell SarcomaEmely Möller, Viviane Praz, Sanalkumar Rajendran, et al.
JCI Insight|September 20, 2019
Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryasTeresa Vanessa Fiorentino, Francesca Casiraghi, Alberto M Davalli, et al.
Nature Metabolism|May 26, 2021
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infectionLaura Montefusco, Moufida Ben Nasr, Francesca D'Addio, et al.
Pharmacological Research|December 31, 2025
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and Type 2 Diabetes via 5-HT2B receptor-dependent mechanismsMartina Colognesi, Daniela Gabbia, Anna Signor, et al.
Pageof 7